These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36531850)

  • 1. Facial Diplegia Complicating Anti-SARS-CoV-2 Vaccinations.
    Finsterer J
    Neurohospitalist; 2023 Jan; 13(1):113-114. PubMed ID: 36531850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
    Juliao Caamaño DS; Alonso Beato R
    J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
    Gaál T; Szeszák G; Torák G; Salacz P
    Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report.
    Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO
    J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report.
    Zubair AS; Bae JY; Desai K
    Cureus; 2022 Feb; 14(2):e22341. PubMed ID: 35371813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 associated Guillain-Barré syndrome.
    Pelea T; Reuter U; Schmidt C; Laubinger R; Siegmund R; Walther BW
    J Neurol; 2021 Apr; 268(4):1191-1194. PubMed ID: 32770414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of proximal muscle weakness, dysarthria, and facial diplegia suggests Guillain-Barre syndrome rather than CIDP.
    Finsterer J
    Egypt J Neurol Psychiatr Neurosurg; 2022; 58(1):161. PubMed ID: 36536685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
    Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
    J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients.
    Finsterer J; Scorza FA; Scorza CA
    Clinics (Sao Paulo); 2021; 76():e3286. PubMed ID: 34644738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination.
    Prasad A; Hurlburt G; Podury S; Tandon M; Kingree S; Sriwastava S
    Neurol Int; 2021 Aug; 13(3):404-409. PubMed ID: 34449715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological side effects of SARS-CoV-2 vaccinations.
    Finsterer J
    Acta Neurol Scand; 2022 Jan; 145(1):5-9. PubMed ID: 34750810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome.
    Finsterer J; Matovu D; Scorza FA
    Clinics (Sao Paulo); 2022; 77():100064. PubMed ID: 35751951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series.
    Kaulen LD; Doubrovinskaia S; Mooshage C; Jordan B; Purrucker J; Haubner C; Seliger C; Lorenz HM; Nagel S; Wildemann B; Bendszus M; Wick W; Schönenberger S
    Eur J Neurol; 2022 Feb; 29(2):555-563. PubMed ID: 34668274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
    Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
    Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.
    Kanabar G; Wilkinson P
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Taste as an Initial Symptom of a "Facial Diplegia and Paresthesia" Variant of Guillain-Barré Syndrome.
    Hiraga A; Muto M; Kuwabara S
    Intern Med; 2022 Oct; 61(19):2957-2959. PubMed ID: 35908975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial Diplegia as a Rare Late Neurologic Manifestation of SARS-CoV-2 Infection.
    Judge C; Moheb N; Castro Apolo R; Dupont JL; Gessner ML; Yacoub HA
    J Neurol Res; 2020 Dec; 10(6):235-236. PubMed ID: 33984099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial Diplegia-Complication or Manifestation of SARS-CoV-2 Infection? A Case Report and Systemic Literature Review.
    Szewczyk AK; Skrobas U; Jamroz-Wiśniewska A; Mitosek-Szewczyk K; Rejdak K
    Healthcare (Basel); 2021 Nov; 9(11):. PubMed ID: 34828542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.